These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33912820)

  • 21. [ANCA-associated vasculitis: recent methodological advances for ANCA detection].
    Csernok E
    Dtsch Med Wochenschr; 2018 Apr; 143(7):499-502. PubMed ID: 29614541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptidylarginine Deiminase Inhibitor Suppresses Neutrophil Extracellular Trap Formation and MPO-ANCA Production.
    Kusunoki Y; Nakazawa D; Shida H; Hattanda F; Miyoshi A; Masuda S; Nishio S; Tomaru U; Atsumi T; Ishizu A
    Front Immunol; 2016; 7():227. PubMed ID: 27375623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation.
    Ma YH; Ma TT; Wang C; Wang H; Chang DY; Chen M; Zhao MH
    Arthritis Res Ther; 2016 Jan; 18():2. PubMed ID: 26739852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
    Hilhorst M; van Paassen P; Tervaert JW;
    J Am Soc Nephrol; 2015 Oct; 26(10):2314-27. PubMed ID: 25956510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
    Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antineutrophil cytoplasmic antibodies (ANCA) - their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis.
    FijoŁek J; Wiatr E
    Cent Eur J Immunol; 2020; 45(2):218-227. PubMed ID: 33456335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis.
    Csernok E
    Antibodies (Basel); 2019 May; 8(2):. PubMed ID: 31544837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage migration inhibitory factor contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation.
    Hao J; Lv TG; Wang C; Xu LP; Zhao JR
    Hum Immunol; 2016 Dec; 77(12):1209-1214. PubMed ID: 27544048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis with a unique imaging presentation of organizing pneumonia: A case report.
    Takada K; Miyamoto A; Nakahama H; Moriguchi S; Takahashi Y; Ogawa K; Murase K; Hanada S; Morokawa N; Kurosaki A; Fujii T; Hasegawa E; Takaya H; Takai D
    Respir Med Case Rep; 2020; 31():101294. PubMed ID: 33294358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy is induced by anti-neutrophil cytoplasmic Abs and promotes neutrophil extracellular traps formation.
    Sha LL; Wang H; Wang C; Peng HY; Chen M; Zhao MH
    Innate Immun; 2016 Nov; 22(8):658-665. PubMed ID: 27670946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of ANCA-associated vasculitis: An update.
    Jarrot PA; Kaplanski G
    Autoimmun Rev; 2016 Jul; 15(7):704-13. PubMed ID: 26970490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical significance of circulating follicular helper T cells in patients with anti-neutrophil cytoplasmic myeloperoxidase antibody-associated vasculitis].
    Wang S; Zheng MJ; Zhou XL; Liu YQ; Shuai ZW
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):738-742. PubMed ID: 30293334
    [No Abstract]   [Full Text] [Related]  

  • 35. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
    Ohlsson S; Holm L; Hansson C; Ohlsson SM; Gunnarsson L; Pettersson Å; Skattum L
    PLoS One; 2019; 14(6):e0218272. PubMed ID: 31216309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.
    Schreiber A; Rousselle A; Becker JU; von Mässenhausen A; Linkermann A; Kettritz R
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9618-E9625. PubMed ID: 29078325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Schreiber A; Kettritz R
    J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
    Holding S; Fisher VJ; Abuzakouk M
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil extracellular traps can activate alternative complement pathways.
    Wang H; Wang C; Zhao MH; Chen M
    Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANCA-Associated Vasculitis Pathogenesis: A Commentary.
    Gapud EJ; Seo P; Antiochos B
    Curr Rheumatol Rep; 2017 Apr; 19(4):15. PubMed ID: 28361331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.